144 related articles for article (PubMed ID: 33200541)
1. Appended Aromatic Moieties in Flexible Bis-3-chloropiperidines Confer Tropism against Pancreatic Cancer Cells.
Carraro C; Helbing T; Francke A; Zuravka I; Sosic A; De Franco M; Gandin V; Gatto B; Göttlich DR
ChemMedChem; 2021 Mar; 16(5):860-868. PubMed ID: 33200541
[TBL] [Abstract][Full Text] [Related]
2. Aromatic Linkers Unleash the Antiproliferative Potential of 3-Chloropiperidines Against Pancreatic Cancer Cells.
Helbing T; Carraro C; Francke A; Sosic A; De Franco M; Gandin V; Göttlich R; Gatto B
ChemMedChem; 2020 Nov; 15(21):2040-2051. PubMed ID: 32744774
[TBL] [Abstract][Full Text] [Related]
3. Bis-3-chloropiperidines containing bridging lysine linkers: Influence of side chain structure on DNA alkylating activity.
Zuravka I; Roesmann R; Sosic A; Göttlich R; Gatto B
Bioorg Med Chem; 2015 Mar; 23(6):1241-50. PubMed ID: 25693786
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and DNA cleavage activity of Bis-3-chloropiperidines as alkylating agents.
Zuravka I; Roesmann R; Sosic A; Wende W; Pingoud A; Gatto B; Göttlich R
ChemMedChem; 2014 Sep; 9(9):2178-85. PubMed ID: 24616300
[TBL] [Abstract][Full Text] [Related]
5. 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety.
Sun J; Ambrus JI; Baker JR; Russell CC; Cossar PJ; Sakoff JA; Scarlett CJ; McCluskey A
Bioorg Med Chem Lett; 2022 Apr; 61():128591. PubMed ID: 35114371
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the cytotoxicity of α-methylene-γ-hydroxy esters against pancreatic cancer.
Ramachandran PV; Helppi MA; Lehmkuhler AL; Marchi JM; Schmidt CM; Yip-Schneider MT
Bioorg Med Chem Lett; 2015 Oct; 25(19):4270-3. PubMed ID: 26264501
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship and mechanistic study on guggulsterone derivatives; Discovery of new anti-pancreatic cancer candidate.
Kohyama A; Kim MJ; Yokoyama R; Sun S; Omar AM; Phan ND; Meselhy MR; Tsuge K; Awale S; Matsuya Y
Bioorg Med Chem; 2022 Jan; 54():116563. PubMed ID: 34942553
[TBL] [Abstract][Full Text] [Related]
8. A novel derivative of valepotriate inhibits the PI3K/AKT pathway and causes Noxa-dependent apoptosis in human pancreatic cancer cells.
Yan YY; Shi KY; Teng F; Chen J; Che JX; Dong XW; Lin NM; Zhang B
Acta Pharmacol Sin; 2020 Jun; 41(6):835-842. PubMed ID: 32047260
[TBL] [Abstract][Full Text] [Related]
9. Structure-cytotoxicity relationship in a series of N-phosphorus substituted E,E-3,5-bis(3-pyridinylmethylene)- and E,E-3,5-bis(4-pyridinylmethylene)piperid-4-ones.
Leonova ES; Makarov MV; Rybalkina EY; Nayani SL; Tongwa P; Fonari A; Timofeeva TV; Odinets IL
Eur J Med Chem; 2010 Dec; 45(12):5926-34. PubMed ID: 21035234
[TBL] [Abstract][Full Text] [Related]
10. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
11. Direct and Topoisomerase II Mediated DNA Damage by Bis-3-chloropiperidines: The Importance of Being an Earnest G.
Sosic A; Zuravka I; Schmitt NK; Miola A; Göttlich R; Fabris D; Gatto B
ChemMedChem; 2017 Sep; 12(17):1471-1479. PubMed ID: 28724198
[TBL] [Abstract][Full Text] [Related]
12. Biological Activity and Physicochemical Properties of Dipeptidyl Nitrile Derivatives Against Pancreatic Ductal Adenocarcinoma Cells.
Quilles JC; Bernardi MDL; Batista PHJ; Silva SCM; Rocha CMR; Montanari CA; Leitão A
Anticancer Agents Med Chem; 2019; 19(1):112-120. PubMed ID: 30370859
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition and mechanism of action of p-dodecylaminophenol against refractory human pancreatic cancer and cholangiocarcinoma.
Imai M; Takahashi N
Bioorg Med Chem; 2012 Apr; 20(8):2520-6. PubMed ID: 22440084
[TBL] [Abstract][Full Text] [Related]
14. Behind the Mirror: Chirality Tunes the Reactivity and Cytotoxicity of Chloropiperidines as Potential Anticancer Agents.
Carraro C; Francke A; Sosic A; Kohl F; Helbing T; De Franco M; Fabris D; Göttlich R; Gatto B
ACS Med Chem Lett; 2019 Apr; 10(4):552-557. PubMed ID: 30996795
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase inhibitor in pancreatic cancer cells.
Shi X; Quan Y; Wang Y; Wang Y; Li Y
Bioorg Med Chem Lett; 2021 Feb; 33():127725. PubMed ID: 33316409
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of 4-amino Substituted 2Hchromen- 2-one Derivatives as an NEDD8 Activating Enzyme Inhibitor in Pancreatic Cancer Cells.
Zhu L; Lu P; Gong L; Lu C; Li M; Wang Y
Med Chem; 2020; 16(7):969-983. PubMed ID: 31880252
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy.
Papeo G; Posteri H; Borghi D; Busel AA; Caprera F; Casale E; Ciomei M; Cirla A; Corti E; D'Anello M; Fasolini M; Forte B; Galvani A; Isacchi A; Khvat A; Krasavin MY; Lupi R; Orsini P; Perego R; Pesenti E; Pezzetta D; Rainoldi S; Riccardi-Sirtori F; Scolaro A; Sola F; Zuccotto F; Felder ER; Donati D; Montagnoli A
J Med Chem; 2015 Sep; 58(17):6875-98. PubMed ID: 26222319
[TBL] [Abstract][Full Text] [Related]
18. A concise diastereoselective approach to enantioenriched substituted piperidines and their in vitro cytotoxicity evaluation.
Kumaraswamy G; Kumar RS; Sampath B; Poornachandra Y; Ganesh Kumar C; Vemulapalli SPB; Bharatam J
Bioorg Med Chem Lett; 2014 Sep; 24(18):4439-4443. PubMed ID: 25172418
[TBL] [Abstract][Full Text] [Related]
19. The design, synthesis and anticancer activity of new nitrogen mustard derivatives of natural indole phytoalexin 1-methoxyspirobrassinol.
Mezencev R; Kutschy P; Salayova A; Updegrove T; McDonald JF
Neoplasma; 2009; 56(4):321-30. PubMed ID: 19473057
[TBL] [Abstract][Full Text] [Related]
20. Impact of Hybrid-polar Histone Deacetylase Inhibitor m-Carboxycinnamic Acid bis-Hydroxyamide on Human Pancreatic Adenocarcinoma Cells.
Kumar D; Sarma P; Bhadra MP; Tangutur AD
Anticancer Agents Med Chem; 2019; 19(6):750-759. PubMed ID: 30621566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
